Launch of Vasofran tablets, a differentiated treatment for hyperlipidemia

 

 

 

KyungDong Pharm launched Vasopran Tablet, a safe hyperlipidemia treatment, in October 2001.
Vasopran tablets are HMG CoA reductase inhibitors and effectively inhibit cholesterol synthesis. Vasopran tablets are an excellent hyperlipidemia treatment that significantly improves the lipid environment in the serum by lowering total cholesterol, LDL cholesterol, and triglycerides and increasing HDL cholesterol.
Additionally, unlike other agents, Vasofran is water-soluble, so it can be safely used clinically.

 

 

Vasofran Jeong

● Ingredients/Content
Pravastatin sodium 5mg per tablet

●Efficacy/Effectiveness
Primary hyperlipidemia: hypercholesterolemia (type IIa)
Combined type of hypercholesterolemia and hypertriglyceridemia (type IIb)

●Usage/Dosage
Adults: As pravastatin sodium, take 10 mg orally per day in 1-2 divided doses, but be sure to follow diet.
In severe cases, the dose may be increased to 20 mg per day.
It increases or decreases appropriately depending on age and symptoms.

●Packing unit
100 tablets